Jiangsu Nhwa Pharmaceutical Co., LTD
As of 18 November 2026, for the company name Jiangsu Nhwa Pharmaceutical Co., LTD as recorded, the chemical-drug catalogue lists 65 active records with this name as holder; 72 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
186 acceptance records as first applicant, grouped into 70 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
依托咪酯中/长链脂肪乳注射液 · No verified English name 2 records · Latest accepted 2026/08/05
Supplement · 2
甲苯磺酸卢美哌隆胶囊 · No verified English name 3 records · Latest accepted 2026/07/15
Generic · 3
Ziprasidone Hydrochloride Capsules 1 records · Latest accepted 2026/07/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2650157 | Supplement | 2026/07/13 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
西诺氨酯片 · No verified English name 3 records · Latest accepted 2026/06/10
Generic · 3
NH130枸橼酸盐片 · No verified English name 7 records · Latest accepted 2026/06/05
New drug · 7
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600672 | New drug | 2026/06/05 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHL2600671 | New drug | 2026/06/05 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHL2600670 | New drug | 2026/06/05 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHL2600669 | New drug | 2026/06/05 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHL2200729 | New drug | 2022/09/23 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHL2200728 | New drug | 2022/09/23 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHL2200727 | New drug | 2022/09/23 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
NH302注射液 · No verified English name 1 records · Latest accepted 2026/06/05
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600673 | New drug | 2026/06/05 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
LevomilnacipranHydrochloride Extended-release Capsules 6 records · Latest accepted 2026/05/14
Generic · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601136 | Generic | 2026/05/14 | Jiangsu Nhwa Pharmaceutical Co., LTD; Jiangsu En Hua Sai De Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2601135 | Generic | 2026/05/14 | Jiangsu Nhwa Pharmaceutical Co., LTD; Jiangsu En Hua Sai De Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2601134 | Generic | 2026/05/14 | Jiangsu Nhwa Pharmaceutical Co., LTD; Jiangsu En Hua Sai De Pharma Co., Ltd. romanized | CDE ↗ |
| CYHL2400031 | Generic | 2024/02/02 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHL2400030 | Generic | 2024/02/02 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHL2400029 | Generic | 2024/02/02 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
右美沙芬安非他酮缓释片 · No verified English name 2 records · Latest accepted 2026/04/30
Generic · 2
奥氮平萨米多芬片 · No verified English name 4 records · Latest accepted 2026/04/13
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2600053 | Generic | 2026/04/13 | Jiangsu Nhwa Pharmaceutical Co., LTD; Suzhou En Hua Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CYHL2600052 | Generic | 2026/04/13 | Jiangsu Nhwa Pharmaceutical Co., LTD; Suzhou En Hua Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CYHL2600051 | Generic | 2026/04/13 | Jiangsu Nhwa Pharmaceutical Co., LTD; Suzhou En Hua Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CYHL2600050 | Generic | 2026/04/13 | Jiangsu Nhwa Pharmaceutical Co., LTD; Suzhou En Hua Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
NH601缓释胶囊 · No verified English name 3 records · Latest accepted 2026/02/14
New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600205 | New drug | 2026/02/14 | Jiangsu Nhwa Pharmaceutical Co., LTD; Suzhou En Hua Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2600204 | New drug | 2026/02/14 | Jiangsu Nhwa Pharmaceutical Co., LTD; Suzhou En Hua Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2600203 | New drug | 2026/02/14 | Jiangsu Nhwa Pharmaceutical Co., LTD; Suzhou En Hua Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
盐酸咪达唑仑口服溶液 · No verified English name 6 records · Latest accepted 2026/01/29
Supplement · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600182 | Supplement | 2026/01/29 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2600181 | Supplement | 2026/01/29 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2600180 | Supplement | 2026/01/29 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2402102 | Supplement | 2024/12/10 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2301300 | Supplement | 2023/06/08 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2301299 | Supplement | 2023/06/08 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
依托咪酯乳状注射液 · No verified English name 2 records · Latest accepted 2025/09/20
Supplement · 2
Sufentanil Citrate Injection 8 records · Latest accepted 2025/08/26
Generic · 4New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2500152 | Generic | 2025/08/26 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHL2500151 | Generic | 2025/08/26 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHL2500150 | Generic | 2025/08/26 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHL2500149 | Generic | 2025/08/26 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHL2500351 | New drug | 2025/04/03 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHL2500350 | New drug | 2025/04/03 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHL2500349 | New drug | 2025/04/03 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHL2500348 | New drug | 2025/04/03 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
NH600001乳状注射液 · No verified English name 3 records · Latest accepted 2025/08/20
New drug · 3
Oxycodone Hydrochloride and Naloxone Hydrochloride Prolonged-release Tablets 1 records · Latest accepted 2025/08/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503050 | Generic | 2025/08/19 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
呫诺美林曲司氯铵胶囊 · No verified English name 3 records · Latest accepted 2025/08/12
Generic · 3
Clonazepam Injection 3 records · Latest accepted 2025/08/01
Supplement · 1Generic · 2
Oxycodone Hydrochloride Injection 9 records · Latest accepted 2025/07/02
Supplement · 9
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501304 | Supplement | 2025/07/02 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2501303 | Supplement | 2025/07/02 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2501302 | Supplement | 2025/07/02 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2500399 | Supplement | 2025/02/27 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2500398 | Supplement | 2025/02/27 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2500397 | Supplement | 2025/02/27 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2302223 | Supplement | 2023/10/09 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2302222 | Supplement | 2023/10/09 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2302221 | Supplement | 2023/10/09 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
盐酸多沙普仑注射液 · No verified English name 1 records · Latest accepted 2025/06/20
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550233 | Supplement | 2025/06/20 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
Oxycodone Hydrochloride Prolonged-release Tablets 2 records · Latest accepted 2025/06/05
Generic · 2
Penehyclidine Hydrochloride Injection 5 records · Latest accepted 2025/05/14
Supplement · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500963 | Supplement | 2025/05/14 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2500962 | Supplement | 2025/05/14 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2350396 | Supplement | 2023/04/28 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2250612 | Supplement | 2022/09/29 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2250611 | Supplement | 2022/09/29 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
Brexpiprazole Tablets 1 records · Latest accepted 2025/04/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501459 | Generic | 2025/04/16 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
NH104片 · No verified English name 2 records · Latest accepted 2025/03/21
New drug · 2
NH140068片 · No verified English name 4 records · Latest accepted 2025/01/08
New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2500035 | New drug | 2025/01/08 | Jiangsu Nhwa Pharmaceutical Co., LTD; Shanghai Shu Jing Bio Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2500034 | New drug | 2025/01/08 | Jiangsu Nhwa Pharmaceutical Co., LTD; Shanghai Shu Jing Bio Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2500033 | New drug | 2025/01/08 | Jiangsu Nhwa Pharmaceutical Co., LTD; Shanghai Shu Jing Bio Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2500032 | New drug | 2025/01/08 | Jiangsu Nhwa Pharmaceutical Co., LTD; Shanghai Shu Jing Bio Technology Co., Ltd. romanized | CDE ↗ |
盐酸他喷他多口服溶液 · No verified English name 1 records · Latest accepted 2024/12/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2400265 | Generic | 2024/12/20 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
枸橼酸芬太尼口腔黏膜贴片 · No verified English name 4 records · Latest accepted 2024/11/07
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401833 | Supplement | 2024/11/07 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2401832 | Supplement | 2024/11/07 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2401831 | Supplement | 2024/11/07 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2401830 | Supplement | 2024/11/07 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
Tiapride Hydrochloride Tablets 1 records · Latest accepted 2024/09/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450475 | Supplement | 2024/09/10 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
NH160030片 · No verified English name 4 records · Latest accepted 2024/09/03
New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2400899 | New drug | 2024/09/03 | Jiangsu Nhwa Pharmaceutical Co., LTD; Shanghai Shu Jing Bio Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2400898 | New drug | 2024/09/03 | Jiangsu Nhwa Pharmaceutical Co., LTD; Shanghai Shu Jing Bio Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2400897 | New drug | 2024/09/03 | Jiangsu Nhwa Pharmaceutical Co., LTD; Shanghai Shu Jing Bio Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2400896 | New drug | 2024/09/03 | Jiangsu Nhwa Pharmaceutical Co., LTD; Shanghai Shu Jing Bio Technology Co., Ltd. romanized | CDE ↗ |
Dexketoprofen Trometamol Injection 2 records · Latest accepted 2024/07/30
Generic · 2
Flumazenil Injection 4 records · Latest accepted 2024/06/28
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400916 | Supplement | 2024/06/28 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2400915 | Supplement | 2024/06/28 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2150901 | Supplement | 2021/10/08 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2150900 | Supplement | 2021/10/08 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
Clozapine Orally Disintegrating Tablets 1 records · Latest accepted 2024/05/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450270 | Supplement | 2024/05/09 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
NH102盐酸盐片 · No verified English name 5 records · Latest accepted 2024/03/28
Supplement · 2New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2400072 | Supplement | 2024/03/28 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHB2400071 | Supplement | 2024/03/28 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHL2100005 | New drug | 2021/01/06 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHL2100004 | New drug | 2021/01/06 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHL2100003 | New drug | 2021/01/06 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
扎来普隆胶囊 · No verified English name 1 records · Latest accepted 2024/03/20
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400405 | Supplement | 2024/03/20 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
Lasmiditan Tablets 2 records · Latest accepted 2024/03/13
Generic · 2
盐酸维洛沙秦缓释胶囊 · No verified English name 2 records · Latest accepted 2024/03/02
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2400050 | Generic | 2024/03/02 | Jiangsu Nhwa Pharmaceutical Co., LTD; Suzhou En Hua Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
| CYHL2400049 | Generic | 2024/03/02 | Jiangsu Nhwa Pharmaceutical Co., LTD; Suzhou En Hua Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
Buspirone Hydrochloride Tablets 3 records · Latest accepted 2024/02/05
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400214 | Supplement | 2024/02/05 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2400213 | Supplement | 2024/02/05 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2250128 | Supplement | 2022/02/21 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
NH103草酸盐片 · No verified English name 8 records · Latest accepted 2024/01/11
New drug · 8
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2400054 | New drug | 2024/01/11 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHL2400053 | New drug | 2024/01/11 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHL2400052 | New drug | 2024/01/11 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHL2400051 | New drug | 2024/01/11 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHL2300960 | New drug | 2023/09/06 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHL2300959 | New drug | 2023/09/06 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHL2300958 | New drug | 2023/09/06 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHL2300957 | New drug | 2023/09/06 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
Remifentanil Hydrochloride for Injection 4 records · Latest accepted 2023/12/26
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303613 | Generic | 2023/12/26 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHS2303612 | Generic | 2023/12/26 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHL2101032 | Generic | 2021/11/03 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHL2101031 | Generic | 2021/11/03 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
Tapentadol Hydrochloride Tablets 6 records · Latest accepted 2023/12/14
Generic · 3Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303460 | Generic | 2023/12/14 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHS2303459 | Generic | 2023/12/14 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHS2303458 | Generic | 2023/12/14 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHB2300135 | Supplement | 2023/07/05 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHB2200009 | Supplement | 2022/01/26 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CXHB2200008 | Supplement | 2022/01/26 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
NH300231肠溶片 · No verified English name 3 records · Latest accepted 2023/10/09
New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2301052 | New drug | 2023/10/09 | Jiangsu Nhwa Pharmaceutical Co., LTD; Shanghai Shu Jing Bio Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2301051 | New drug | 2023/10/09 | Jiangsu Nhwa Pharmaceutical Co., LTD; Shanghai Shu Jing Bio Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2301050 | New drug | 2023/10/09 | Jiangsu Nhwa Pharmaceutical Co., LTD; Shanghai Shu Jing Bio Technology Co., Ltd. romanized | CDE ↗ |
盐酸(R)氯胺酮鼻用喷雾剂 · No verified English name 1 records · Latest accepted 2023/09/23
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2301028 | New drug | 2023/09/23 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
Riluzole Tablets 1 records · Latest accepted 2023/09/12
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350689 | Supplement | 2023/09/12 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
Vortioxetine Hydrobromide Tablets 1 records · Latest accepted 2023/09/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302448 | Generic | 2023/09/12 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
Mivacurium Chloride Injection 2 records · Latest accepted 2023/08/14
Generic · 2
Tapentadol Hydrochloride Extended Release Tablets 2 records · Latest accepted 2023/08/02
Generic · 2
Cariprazine hydrochloride Capsules 2 records · Latest accepted 2023/07/13
Generic · 2
Alfentanil Hydrochloride Injection 1 records · Latest accepted 2023/06/07
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2301286 | Supplement | 2023/06/07 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
NH300231片 · No verified English name 3 records · Latest accepted 2023/04/21
New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2300408 | New drug | 2023/04/21 | Jiangsu Nhwa Pharmaceutical Co., LTD; Shanghai Shu Jing Bio Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2300407 | New drug | 2023/04/21 | Jiangsu Nhwa Pharmaceutical Co., LTD; Shanghai Shu Jing Bio Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2300406 | New drug | 2023/04/21 | Jiangsu Nhwa Pharmaceutical Co., LTD; Shanghai Shu Jing Bio Technology Co., Ltd. romanized | CDE ↗ |
Ziprasidone Mesylate for Injection 2 records · Latest accepted 2023/04/14
Supplement · 2
盐酸(R)氯胺酮注射液 · No verified English name 1 records · Latest accepted 2023/03/24
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2300327 | New drug | 2023/03/24 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
Midazolam Nasal Spray 1 records · Latest accepted 2023/03/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2300030 | Generic | 2023/03/02 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
Fentanyl Citrate Injection 2 records · Latest accepted 2022/11/10
Supplement · 2
Lacosamide Injection 1 records · Latest accepted 2022/10/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201782 | Generic | 2022/10/20 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
NHL35700片 · No verified English name 3 records · Latest accepted 2022/10/13
New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2200793 | New drug | 2022/10/13 | Jiangsu Nhwa Pharmaceutical Co., LTD; Shanghai Shu Jing Bio Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2200792 | New drug | 2022/10/13 | Jiangsu Nhwa Pharmaceutical Co., LTD; Shanghai Shu Jing Bio Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2200791 | New drug | 2022/10/13 | Jiangsu Nhwa Pharmaceutical Co., LTD; Shanghai Shu Jing Bio Technology Co., Ltd. romanized | CDE ↗ |
Alprazolam Tablets 1 records · Latest accepted 2022/10/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250637 | Supplement | 2022/10/13 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
Brivaracetam Solution for Injection 1 records · Latest accepted 2022/09/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2200079 | Generic | 2022/09/16 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
Pregabalin Extended release Tablets 1 records · Latest accepted 2022/08/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2200073 | Generic | 2022/08/26 | Jiangsu Nhwa Pharmaceutical Co., LTD; Suzhou En Hua Biopharmaceuticals Technology Co., Ltd. romanized | CDE ↗ |
Pregabalin Capsules 1 records · Latest accepted 2022/08/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201265 | Generic | 2022/08/09 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
NH300094片 · No verified English name 3 records · Latest accepted 2022/06/23
New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2200409 | New drug | 2022/06/23 | Jiangsu Nhwa Pharmaceutical Co., LTD; Shanghai Shu Jing Bio Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2200408 | New drug | 2022/06/23 | Jiangsu Nhwa Pharmaceutical Co., LTD; Shanghai Shu Jing Bio Technology Co., Ltd. romanized | CDE ↗ |
| CXHL2200407 | New drug | 2022/06/23 | Jiangsu Nhwa Pharmaceutical Co., LTD; Shanghai Shu Jing Bio Technology Co., Ltd. romanized | CDE ↗ |
Amisulpride Injection 2 records · Latest accepted 2022/05/06
Generic · 2
Oliceridine Fumarate Injection 4 records · Latest accepted 2022/04/01
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200516 | Generic | 2022/04/01 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHS2200224 | Generic | 2022/01/28 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHS2200223 | Generic | 2022/01/28 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHS2200222 | Generic | 2022/01/28 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
lorazepam injection 1 records · Latest accepted 2022/02/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2200016 | Generic | 2022/02/11 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
利培酮分散片 · No verified English name 1 records · Latest accepted 2021/12/01
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2102221 | Supplement | 2021/12/01 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
Risperidone Tablets 1 records · Latest accepted 2021/12/01
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2102220 | Supplement | 2021/12/01 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
Duloxetine Hydrochloride Enteric Capsules 3 records · Latest accepted 2021/11/30
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2102216 | Supplement | 2021/11/30 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2102215 | Supplement | 2021/11/30 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2102214 | Supplement | 2021/11/30 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
Midazolam Injection 5 records · Latest accepted 2021/10/27
Supplement · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150950 | Supplement | 2021/10/27 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2101160 | Supplement | 2021/04/23 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2101159 | Supplement | 2021/04/23 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2101158 | Supplement | 2021/04/23 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| CYHB2101157 | Supplement | 2021/04/23 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
Olanzapine Tablets 2 records · Latest accepted 2021/04/02
Generic · 2
丙泊酚乳状注射液 · No verified English name 1 records · Latest accepted 2021/02/08
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2100229 | Supplement | 2021/02/08 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
地佐辛 · No verified English name 1 records · Latest accepted 2018/01/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS1700139 | Generic | 2018/01/18 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
地佐辛注射液 · No verified English name 2 records · Latest accepted 2018/01/18
Generic · 2
Changes in the last 90 days
10 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Marketing application approved: 1 applicationNo longer listed under review: 5 applicationsSupplement delivery: 4 applications
- 2026/11/10Marketing application approved
Oxycodone Hydrochloride Prolonged-release Tablets
CYHS2501993 · 国药准字H20266566
Fact date: 2026/11/10 · Publication date: 2026/11/13 · Date added to this site: 2026/11/14
View source · Table row 77 ↗ - 2026/11/06No longer listed under review
依托咪酯中/长链脂肪乳注射液 · No verified English name
CYHB2601503
Fact date: 2026/11/06 · Date added to this site: 2026/11/06
Accepted: 2026/08/05
no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/04); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 24
NMPA · Table row 24 ↗ View source ↗ - 2026/11/04Supplement delivery
依托咪酯中/长链脂肪乳注射液 · No verified English name
CYHB2601503
Fact date: 2026/11/04 · Publication date: 2026/11/06 · Date added to this site: 2026/11/06
Supplemental application; excluded from new marketing approvals.
View source · Table row 24 ↗ - 2026/10/29No longer listed under review
盐酸咪达唑仑口服溶液 · No verified English name
CYHB2600182
Fact date: 2026/10/29 · Date added to this site: 2026/10/29
Accepted: 2026/01/29
no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/10/29 (approval no.: —; approval date: 2026/10/27); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 6
NMPA · Table row 6 ↗ View source ↗ - 2026/10/29No longer listed under review
盐酸咪达唑仑口服溶液 · No verified English name
CYHB2600181
Fact date: 2026/10/29 · Date added to this site: 2026/10/29
Accepted: 2026/01/29
no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/10/29 (approval no.: —; approval date: 2026/10/27); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 5
NMPA · Table row 5 ↗ View source ↗ - 2026/10/29No longer listed under review
盐酸咪达唑仑口服溶液 · No verified English name
CYHB2600180
Fact date: 2026/10/29 · Date added to this site: 2026/10/29
Accepted: 2026/01/29
no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/10/29 (approval no.: —; approval date: 2026/10/27); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 4
NMPA · Table row 4 ↗ View source ↗ - 2026/10/28No longer listed under review
Oxycodone Hydrochloride Prolonged-release Tablets
CYHS2501993
Fact date: 2026/10/28 · Date added to this site: 2026/10/28
Accepted: 2025/06/05
no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/11/13 (approval no.: 国药准字H20266566; approval date: 2026/11/10) · NMPA source · row 77
NMPA · Table row 77 ↗ View source ↗ - 2026/10/27Supplement delivery
盐酸咪达唑仑口服溶液 · No verified English name
CYHB2600182
Fact date: 2026/10/27 · Publication date: 2026/10/29 · Date added to this site: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 6 ↗ - 2026/10/27Supplement delivery
盐酸咪达唑仑口服溶液 · No verified English name
CYHB2600181
Fact date: 2026/10/27 · Publication date: 2026/10/29 · Date added to this site: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 5 ↗ - 2026/10/27Supplement delivery
盐酸咪达唑仑口服溶液 · No verified English name
CYHB2600180
Fact date: 2026/10/27 · Publication date: 2026/10/29 · Date added to this site: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 4 ↗
Under review
15 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 甲苯磺酸卢美哌隆胶囊 · No verified English name | CYHS2601686 | Generic | 2026/07/15 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| 甲苯磺酸卢美哌隆胶囊 · No verified English name | CYHS2601685 | Generic | 2026/07/15 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| Ziprasidone Hydrochloride Capsules | CYHB2650157 | Supplement | 2026/07/13 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| 西诺氨酯片 · No verified English name | CYHS2601366 | Generic | 2026/06/10 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| 西诺氨酯片 · No verified English name | CYHS2601365 | Generic | 2026/06/10 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| 西诺氨酯片 · No verified English name | CYHS2601364 | Generic | 2026/06/10 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| LevomilnacipranHydrochloride Extended-release Capsules | CYHS2601136 | Generic | 2026/05/14 | Jiangsu Nhwa Pharmaceutical Co., LTD; Jiangsu En Hua Sai De Pharma Co., Ltd. romanized | CDE ↗ |
| LevomilnacipranHydrochloride Extended-release Capsules | CYHS2601135 | Generic | 2026/05/14 | Jiangsu Nhwa Pharmaceutical Co., LTD; Jiangsu En Hua Sai De Pharma Co., Ltd. romanized | CDE ↗ |
| LevomilnacipranHydrochloride Extended-release Capsules | CYHS2601134 | Generic | 2026/05/14 | Jiangsu Nhwa Pharmaceutical Co., LTD; Jiangsu En Hua Sai De Pharma Co., Ltd. romanized | CDE ↗ |
| 右美沙芬安非他酮缓释片 · No verified English name | CYHS2601007 | Generic | 2026/04/30 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| 依托咪酯乳状注射液 · No verified English name | CYHB2501858 | Supplement | 2025/09/20 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| NH600001乳状注射液 · No verified English name | CXHS2500099 | New drug | 2025/08/20 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| 地佐辛注射液 · No verified English name | CYHS1700141 | Generic | 2018/01/18 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| 地佐辛 · No verified English name | CYHS1700139 | Generic | 2018/01/18 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| 地佐辛注射液 · No verified English name | CYHS1700140 | Generic | 2018/01/17 | Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
Catalogue holder records
65 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 盐酸多沙普仑注射液 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H32022989 | 2026/06/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Dexketoprofen Trometamol Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20263067 | 2026/01/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tiapride Hydrochloride Tablets | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H32025477 | 2025/12/01 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Oxycodone Hydrochloride Prolonged-release Tablets | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20256076 | 2025/11/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tapentadol Hydrochloride Tablets | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20255472 | 2025/09/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tapentadol Hydrochloride Tablets | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20255471 | 2025/09/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tapentadol Hydrochloride Tablets | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20255473 | 2025/09/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Clozapine Orally Disintegrating Tablets | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20100105 | 2025/04/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Vortioxetine Hydrobromide Tablets | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20253153 | 2025/01/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mivacurium Chloride Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20249405 | 2024/11/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mivacurium Chloride Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20249404 | 2024/11/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Buspirone Hydrochloride Tablets | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20247244 | 2024/10/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Buspirone Hydrochloride Tablets | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20247245 | 2024/10/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Clonazepam Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20249045 | 2024/10/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ziprasidone Mesylate for Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20090056 | 2024/09/19 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ziprasidone Mesylate for Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20247214 | 2024/09/19 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Riluzole Tablets | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20045977 | 2024/07/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Penehyclidine Hydrochloride Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20203004 | 2024/06/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Pregabalin Capsules | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20243979 | 2024/06/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lacosamide Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20243708 | 2024/05/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Alfentanil Hydrochloride Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20247083 | 2024/04/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Fentanyl Citrate Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20113508 | 2023/12/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Fentanyl Citrate Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20113509 | 2023/12/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Alprazolam Tablets | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H32020215 | 2023/11/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Penehyclidine Hydrochloride Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20203003 | 2023/06/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Penehyclidine Hydrochloride Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20203005 | 2023/06/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 富马酸奥赛利定注射液 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20233509 | 2023/04/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 富马酸奥赛利定注射液 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20233508 | 2023/04/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 富马酸奥赛利定注射液 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20233510 | 2023/04/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 富马酸奥赛利定注射液 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20233511 | 2023/04/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Buspirone Hydrochloride Tablets | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H19991024 | 2023/04/27 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Flumazenil Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20143151 | 2022/09/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Flumazenil Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20055902 | 2022/09/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Midazolam Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20143222 | 2022/08/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Olanzapine Tablets | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20223572 | 2022/08/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olanzapine Tablets | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20223573 | 2022/08/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sulpiride Tablets | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H32022971 | 2021/12/13 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Alfentanil Hydrochloride Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20213853 | 2021/11/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Alfentanil Hydrochloride Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20213854 | 2021/11/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Duloxetine Hydrochloride Enteric Capsules | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20213481 | 2021/06/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Duloxetine Hydrochloride Enteric Capsules | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20213480 | 2021/06/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Duloxetine Hydrochloride Enteric Capsules | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20213482 | 2021/06/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Remifentanil Hydrochloride for Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20143315 | 2021/06/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Remifentanil Hydrochloride for Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20143314 | 2021/06/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Clonazepam Tablets | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H10930004 | 2021/05/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Aripiprazole Tablets | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20140121 | 2021/03/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Oxycodone Hydrochloride Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20213141 | 2021/02/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oxycodone Hydrochloride Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20213140 | 2021/02/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Oxycodone Hydrochloride Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20213142 | 2021/02/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Midazolam Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H19990027 | 2021/02/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Midazolam Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20031071 | 2021/02/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Midazolam Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H10980025 | 2021/02/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Midazolam Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20031037 | 2021/02/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Dexmedetomidine Hydrochloride Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20110085 | 2021/01/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Dexmedetomidine Hydrochloride Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20133331 | 2021/01/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Sufentanil Citrate Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20203653 | 2020/12/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sufentanil Citrate Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20203652 | 2020/12/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sufentanil Citrate Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20203651 | 2020/12/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sufentanil Citrate Injection | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20203650 | 2020/12/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gabapentin Capsules | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20051068 | 2020/05/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Gabapentin Capsules | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20051067 | 2020/05/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Gabapentin Capsules | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20040527 | 2020/05/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 利培酮分散片 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20100106 | 2019/11/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Clozapine Tablets | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H32022963 | 2019/10/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Risperidone Tablets | Jiangsu Nhwa Pharmaceutical Co., LTD | Jiangsu Nhwa Pharmaceutical Co., LTD | 国药准字H20050160 | 2019/01/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
72 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 盐酸哌罗匹隆 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20260000772 | I | 2026/09/08 | CDE ↗ |
| 甲苯磺酸卢美哌隆 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20260000415 | I | 2026/05/26 | CDE ↗ |
| 西诺氨酯 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20260000390 | I | 2026/05/12 | CDE ↗ |
| 酒石酸呫诺美林 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20260000386 | I | 2026/05/12 | CDE ↗ |
| 盐酸安非他酮 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20260000246 | I | 2026/03/30 | CDE ↗ |
| 盐酸左米那普仑 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20250001254 | I | 2026/03/23 | CDE ↗ |
| 帕利哌酮 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20250000957 | I | 2025/09/05 | CDE ↗ |
| 盐酸维洛沙秦 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20250000855 | I | 2025/08/22 | CDE ↗ |
| 盐酸氯胺酮 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20250000820 | I | 2025/08/13 | CDE ↗ |
| NH600001 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20250000697 | I | 2025/07/30 | CDE ↗ |
| 盐酸左美沙酮 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20250000632 | I | 2025/07/08 | CDE ↗ |
| 布瑞哌唑 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20250000258 | A | 2026/08/06 | CDE ↗ |
| 盐酸硫必利 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20240000763 | A | 2025/11/10 | CDE ↗ |
| 右酮洛芬氨丁三醇 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20240000499 | A | 2026/01/25 | CDE ↗ |
| 劳拉西泮 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20240000388 | A | 2025/09/30 | CDE ↗ |
| 氢溴酸伏硫西汀 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20230000789 | A | 2025/01/23 | CDE ↗ |
| 米库氯铵 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20230000574 | A | 2024/11/24 | CDE ↗ |
| 富马酸奥赛利定 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20210001272 | A | 2025/07/30 | CDE ↗ |
| 盐酸他喷他多 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20210001193 | A | 2025/09/24 | CDE ↗ |
| 氯氮平 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20210000420 | A | 2023/04/13 | CDE ↗ |
| 枸橼酸舒芬太尼 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190021647 | A | 2026/11/05 | CDE ↗ |
| 盐酸咪达唑仑 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20200000399 | A | 2023/06/21 | CDE ↗ |
| CY150112 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20200000220 | I | 2022/10/09 | CDE ↗ |
| 舒必利 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20200000177 | A | 2026/11/02 | CDE ↗ |
| Oliceridine 富马酸盐 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20200000127 | I | 2022/09/15 | CDE ↗ |
| 盐酸齐拉西酮 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190009730 | A | — | CDE ↗ |
| 氢溴酸西酞普兰 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190009588 | A | — | CDE ↗ |
| 利培酮 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190009586 | A | — | CDE ↗ |
| 硝酸咪康唑 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190009584 | A | — | CDE ↗ |
| 硝酸益康唑 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190009583 | A | — | CDE ↗ |
| 氯硝西泮 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190009582 | A | — | CDE ↗ |
| 盐酸纳洛酮 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190009581 | A | 2025/06/26 | CDE ↗ |
| 甲磺酸齐拉西酮 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190007393 | A | 2024/10/09 | CDE ↗ |
| 盐酸度洛西汀 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190007215 | A | 2023/03/02 | CDE ↗ |
| 丙泊酚 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190006648 | A | 2024/11/07 | CDE ↗ |
| 枸橼酸芬太尼 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190006561 | A | 2026/08/06 | CDE ↗ |
| 盐酸右美托咪定 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190006376 | A | 2025/12/04 | CDE ↗ |
| 维库溴铵 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190006367 | A | 2026/02/10 | CDE ↗ |
| 加巴喷丁 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190004231 | A | 2025/06/28 | CDE ↗ |
| 西洛他唑 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190004221 | A | 2024/01/17 | CDE ↗ |
| 三唑仑 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190004078 | A | 2025/07/18 | CDE ↗ |
| 利鲁唑 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190004077 | A | 2025/06/26 | CDE ↗ |
| 扎来普隆 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190004076 | A | 2025/06/26 | CDE ↗ |
| 盐酸氯米帕明 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190004054 | A | 2025/11/21 | CDE ↗ |
| 甲磺酸罗哌卡因 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190004053 | A | 2025/06/26 | CDE ↗ |
| 碳酸锂 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190003917 | A | 2025/05/27 | CDE ↗ |
| 萘普生 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190003916 | A | 2025/06/26 | CDE ↗ |
| 氟马西尼 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190003915 | A | 2025/07/18 | CDE ↗ |
| 马来酸咪达唑仑 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190003914 | A | 2025/07/18 | CDE ↗ |
| 咪达唑仑 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190003911 | A | 2025/06/28 | CDE ↗ |
| 非诺贝特 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190003910 | A | 2025/06/13 | CDE ↗ |
| 酮康唑 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190003909 | A | 2026/06/22 | CDE ↗ |
| 尼扎替丁 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190003908 | A | 2025/11/22 | CDE ↗ |
| 硝西泮 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190003890 | A | 2025/06/28 | CDE ↗ |
| 盐酸多沙普仑 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190003882 | A | 2025/06/26 | CDE ↗ |
| 依托咪酯 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190003881 | A | 2025/06/28 | CDE ↗ |
| 盐酸丁螺环酮 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190003880 | A | 2025/07/18 | CDE ↗ |
| 阿立哌唑 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190001422 | A | 2024/12/28 | CDE ↗ |
| 盐酸阿芬太尼 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20190000841 | A | 2026/11/02 | CDE ↗ |
| 利培酮 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20170002168 | A | 2025/08/12 | CDE ↗ |
| 盐酸齐拉西酮 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20170002014 | A | 2026/01/23 | CDE ↗ |
| 盐酸纳洛酮 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20170002013 | I | — | CDE ↗ |
| 硝酸益康唑 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20170002003 | A | 2026/08/18 | CDE ↗ |
| 硝酸咪康唑 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20170002001 | A | 2026/07/07 | CDE ↗ |
| 氢溴酸西酞普兰 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20170001973 | A | 2025/07/18 | CDE ↗ |
| 氯硝西泮 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20170001892 | A | 2025/06/28 | CDE ↗ |
| 普瑞巴林 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20170001560 | A | 2023/07/14 | CDE ↗ |
| 富马酸喹硫平 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20170001025 | A | 2024/08/29 | CDE ↗ |
| 盐酸帕罗西汀 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20170000941 | I | — | CDE ↗ |
| 氟曲马唑 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20170000865 | A | 2023/07/14 | CDE ↗ |
| 盐酸戊乙奎醚 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20170000844 | A | 2024/12/28 | CDE ↗ |
| 奥氮平 · No verified English name | Jiangsu Nhwa Pharmaceutical Co., LTD | Y20170000211 | A | 2024/05/01 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
6 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| NHL35700片 · No verified English name | CXHB2600015 | Supplement | 2026/01/22 | Shanghai Shu Jing Bio Technology Co., Ltd. romanized; Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| NHL35700片 · No verified English name | CXHB2600014 | Supplement | 2026/01/22 | Shanghai Shu Jing Bio Technology Co., Ltd. romanized; Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| 依托咪酯中/长链脂肪乳注射液 · No verified English name | CYHB2301753 | Supplement | 2023/08/01 | Jiangsu Yuan Heng Pharma Co., Ltd. romanized; Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| NHL35700片 · No verified English name | CXHB2300091 | Supplement | 2023/04/10 | Shanghai Shu Jing Bio Technology Co., Ltd. romanized; Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| NHL35700片 · No verified English name | CXHB2300090 | Supplement | 2023/04/10 | Shanghai Shu Jing Bio Technology Co., Ltd. romanized; Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
| NHL35700片 · No verified English name | CXHB2300089 | Supplement | 2023/04/10 | Shanghai Shu Jing Bio Technology Co., Ltd. romanized; Jiangsu Nhwa Pharmaceutical Co., LTD | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.